North America Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Application (Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others), By Technology, By Country and Growth Forecast, 2024 - 2031
Published Date : 01-Jul-2024 |
Pages: 124 |
Formats: PDF |
COVID-19 Impact on the North America Laboratory Developed Tests Market
Market Overview
The North America Laboratory Developed Tests Market would witness market growth of 6.6% CAGR during the forecast period (2024-2031).
The US market dominated the North America Laboratory Developed Tests Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $5,628.1 million by 2031. The Canada market is experiencing a CAGR of 6.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2024 - 2031).
LDTs find applications across various healthcare domains, spanning diagnostic testing, disease monitoring, therapeutic decision-making, and research. These tests are utilized in diverse clinical settings, including hospital laboratories, reference laboratories, academic research centers, and specialized diagnostic facilities. LDTs are used for the diagnosis of a wide range of diseases and conditions, including infectious diseases, cancer, cardiovascular disorders, autoimmune disorders, and genetic disorders.
In addition, LDTs play a critical role in patient stratification and personalized medicine by identifying molecular subtypes, treatment targets, and predictive biomarkers associated with differential treatment responses or disease outcomes. These tests facilitate selecting optimal treatment strategies tailored to individual patient characteristics, genetic profiles, and clinical contexts.
As healthcare expenditure increases in Canada, there is a corresponding rise in demand for diagnostic testing across various medical specialties and disease areas. According to the Canadian government, the provinces and territories will get an additional $46.2 billion in financing as part of a $196.1 billion ten-year investment by the government to enhance health care services for all Canadians. This brings the total amount of money it will spend over ten years from $198.6 billion to $12.5 billion for supporting indigenous goals and supplementary government support. Likewise, as cancer rates rise in Mexico, there is a growing demand for screening and diagnostic tests to detect cancer at early stages when treatment is most effective. Mexico’s third most common cause of death, according to All.Can, is cancer. In 2020, around 195,000 new cases were reported. The cancers with the highest prevalence were cervical (9,439), thyroid (11,227), colon (11,191), prostate (26.742), breast (29.929), and thyroid (11,227). Thus, rising healthcare spending and high cancer rates propel the market’s expansion.
Free Valuable Insights: The Laboratory Developed Tests Market is Predict to reach USD 20.3 Billion by 2031, at a CAGR of 6.9%
Based on Application, the market is segmented into Oncology, Genetic Disorders/Inherited Disease, Infectious & Parasitic Diseases, Endocrine, Immunology, Nutritional & Metabolic Disease, Cardiology, Mental/Behavioral Disorder, Pediatrics-specific Testing, and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Immunoassays, Hematology & Coagulation, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Neogenomics, Inc.
- Guardant Health, Inc.
- Qiagen N.V
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Siemens Healthineers AG (Siemens AG)
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- F.Hoffmann-La Roche Ltd.
- Eurofins Scientific SE
North America Laboratory Developed Tests Market Report Segmentation
By Application
- Oncology
- Genetic Disorders/Inherited Disease
- Infectious & Parasitic Diseases
- Endocrine
- Immunology
- Nutritional & Metabolic Disease
- Cardiology
- Mental/Behavioral Disorder
- Pediatrics-specific Testing
- Others
By Technology
- Molecular Diagnostics
- Immunoassays
- Hematology & Coagulation
- Microbiology
- Clinical Chemistry
- Histology/Cytology
- Flow Cytometry
- Mass Spectroscopy
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Laboratory Developed Tests Market, by Application
1.4.2 North America Laboratory Developed Tests Market, by Technology
1.4.3 North America Laboratory Developed Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.
Chapter 5. North America Laboratory Developed Tests Market by Application
5.1 North America Oncology Market by Country
5.2 North America Genetic Disorders/Inherited Disease Market by Country
5.3 North America Infectious & Parasitic Diseases Market by Country
5.4 North America Endocrine Market by Country
5.5 North America Immunology Market by Country
5.6 North America Nutritional & Metabolic Disease Market by Country
5.7 North America Cardiology Market by Country
5.8 North America Mental/Behavioral Disorder Market by Country
5.9 North America Pediatrics-specific Testing Market by Country
5.1 North America Others Market by Country
Chapter 6. North America Laboratory Developed Tests Market by Technology
6.1 North America Molecular Diagnostics Market by Country
6.2 North America Immunoassays Market by Country
6.3 North America Hematology & Coagulation Market by Country
6.4 North America Microbiology Market by Country
6.5 North America Clinical Chemistry Market by Country
6.6 North America Histology/Cytology Market by Country
6.7 North America Flow Cytometry Market by Country
6.8 North America Mass Spectroscopy Market by Country
6.9 North America Others Market by Country
Chapter 7. North America Laboratory Developed Tests Market by Country
7.1 US Laboratory Developed Tests Market
7.1.1 US Laboratory Developed Tests Market by Application
7.1.2 US Laboratory Developed Tests Market by Technology
7.2 Canada Laboratory Developed Tests Market
7.2.1 Canada Laboratory Developed Tests Market by Application
7.2.2 Canada Laboratory Developed Tests Market by Technology
7.3 Mexico Laboratory Developed Tests Market
7.3.1 Mexico Laboratory Developed Tests Market by Application
7.3.2 Mexico Laboratory Developed Tests Market by Technology
7.4 Rest of North America Laboratory Developed Tests Market
7.4.1 Rest of North America Laboratory Developed Tests Market by Application
7.4.2 Rest of North America Laboratory Developed Tests Market by Technology
Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Laboratory Developed Tests Market, by Application
1.4.2 North America Laboratory Developed Tests Market, by Technology
1.4.3 North America Laboratory Developed Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Laboratory Developed Tests Market.
Chapter 5. North America Laboratory Developed Tests Market by Application
5.1 North America Oncology Market by Country
5.2 North America Genetic Disorders/Inherited Disease Market by Country
5.3 North America Infectious & Parasitic Diseases Market by Country
5.4 North America Endocrine Market by Country
5.5 North America Immunology Market by Country
5.6 North America Nutritional & Metabolic Disease Market by Country
5.7 North America Cardiology Market by Country
5.8 North America Mental/Behavioral Disorder Market by Country
5.9 North America Pediatrics-specific Testing Market by Country
5.1 North America Others Market by Country
Chapter 6. North America Laboratory Developed Tests Market by Technology
6.1 North America Molecular Diagnostics Market by Country
6.2 North America Immunoassays Market by Country
6.3 North America Hematology & Coagulation Market by Country
6.4 North America Microbiology Market by Country
6.5 North America Clinical Chemistry Market by Country
6.6 North America Histology/Cytology Market by Country
6.7 North America Flow Cytometry Market by Country
6.8 North America Mass Spectroscopy Market by Country
6.9 North America Others Market by Country
Chapter 7. North America Laboratory Developed Tests Market by Country
7.1 US Laboratory Developed Tests Market
7.1.1 US Laboratory Developed Tests Market by Application
7.1.2 US Laboratory Developed Tests Market by Technology
7.2 Canada Laboratory Developed Tests Market
7.2.1 Canada Laboratory Developed Tests Market by Application
7.2.2 Canada Laboratory Developed Tests Market by Technology
7.3 Mexico Laboratory Developed Tests Market
7.3.1 Mexico Laboratory Developed Tests Market by Application
7.3.2 Mexico Laboratory Developed Tests Market by Technology
7.4 Rest of North America Laboratory Developed Tests Market
7.4.1 Rest of North America Laboratory Developed Tests Market by Application
7.4.2 Rest of North America Laboratory Developed Tests Market by Technology
Chapter 8. Company Profiles
8.1 Neogenomics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 Guardant Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Qiagen N.V.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Quest Diagnostics Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.4.5 SWOT Analysis
8.5 Abbott Laboratories
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segment and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Bio-Rad laboratories, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Eurofins Scientific SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 SWOT Analysis
List of Tables
TABLE 1 North America Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 2 North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 3 North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 4 North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 5 North America Oncology Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Oncology Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Endocrine Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Endocrine Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Immunology Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Immunology Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 26 North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 27 North America Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Immunoassays Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Immunoassays Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Microbiology Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Microbiology Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Clinical Chemistry Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Clinical Chemistry Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Histology/Cytology Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Histology/Cytology Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Flow Cytometry Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Flow Cytometry Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
TABLE 47 US Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 48 US Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 49 US Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 50 US Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 51 US Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 52 US Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 53 Canada Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 54 Canada Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 55 Canada Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 56 Canada Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 57 Canada Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 58 Canada Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 59 Mexico Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 60 Mexico Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 61 Mexico Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 62 Mexico Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 63 Mexico Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 64 Mexico Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 65 Rest of North America Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 66 Rest of North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 67 Rest of North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 68 Rest of North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 69 Rest of North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 70 Rest of North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 71 Key Information – neogenomics, inc.
TABLE 72 Key Information – GUARDANT HEALTH, INC.
TABLE 73 Key Information – Qiagen N.V.
TABLE 74 Key information – Quest Diagnostics Incorporated
TABLE 75 Key Information – Abbott Laboratories
TABLE 76 Key Information – Siemens Healthineers AG
TABLE 77 key information – Illumina, Inc.
TABLE 78 Key Information – Bio-Rad Laboratories, Inc.
TABLE 79 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 80 Key Information – Eurofins Scientific SE
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Laboratory Developed Tests Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Laboratory Developed Tests Market
FIG 4 Porter’s Five Forces Analysis – Laboratory Developed Tests Market
FIG 5 North America Laboratory Developed Tests Market share by Application, 2023
FIG 6 North America Laboratory Developed Tests Market share by Application, 2031
FIG 7 North America Laboratory Developed Tests Market by Application, 2020 - 2031, USD Million
FIG 8 North America Laboratory Developed Tests Market share by Technology, 2023
FIG 9 North America Laboratory Developed Tests Market share by Technology, 2031
FIG 10 North America Laboratory Developed Tests Market by Technology, 2020 - 2031, USD Million
FIG 11 North America Laboratory Developed Tests Market share by Country, 2023
FIG 12 North America Laboratory Developed Tests Market share by Country, 2031
FIG 13 North America Laboratory Developed Tests Market by Country, 2020 - 2031, USD Million
FIG 14 Swot Analysis: Neogenomics, Inc.
FIG 15 Swot Analysis: Guardant Health, Inc.
FIG 16 Recent strategies and developments: Qiagen N.V.
FIG 17 Swot Analysis: Qiagen N.V.
FIG 18 SWOT Analysis: Quest Diagnostics Incorporated
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 SWOT Analysis: Eurofins Scientific SEs
TABLE 2 North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 3 North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 4 North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 5 North America Oncology Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Oncology Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Genetic Disorders/Inherited Disease Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Genetic Disorders/Inherited Disease Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Infectious & Parasitic Diseases Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Infectious & Parasitic Diseases Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Endocrine Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Endocrine Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Immunology Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Immunology Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Nutritional & Metabolic Disease Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Nutritional & Metabolic Disease Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Cardiology Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Cardiology Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Mental/Behavioral Disorder Market by Country, 2020 - 2023, USD Million
TABLE 20 North America Mental/Behavioral Disorder Market by Country, 2024 - 2031, USD Million
TABLE 21 North America Pediatrics-specific Testing Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Pediatrics-specific Testing Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 26 North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 27 North America Molecular Diagnostics Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Molecular Diagnostics Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Immunoassays Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Immunoassays Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Hematology & Coagulation Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Hematology & Coagulation Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Microbiology Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Microbiology Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Clinical Chemistry Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Clinical Chemistry Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Histology/Cytology Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Histology/Cytology Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Flow Cytometry Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Flow Cytometry Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Mass Spectroscopy Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Mass Spectroscopy Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Laboratory Developed Tests Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Laboratory Developed Tests Market by Country, 2024 - 2031, USD Million
TABLE 47 US Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 48 US Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 49 US Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 50 US Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 51 US Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 52 US Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 53 Canada Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 54 Canada Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 55 Canada Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 56 Canada Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 57 Canada Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 58 Canada Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 59 Mexico Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 60 Mexico Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 61 Mexico Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 62 Mexico Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 63 Mexico Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 64 Mexico Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 65 Rest of North America Laboratory Developed Tests Market, 2020 - 2023, USD Million
TABLE 66 Rest of North America Laboratory Developed Tests Market, 2024 - 2031, USD Million
TABLE 67 Rest of North America Laboratory Developed Tests Market by Application, 2020 - 2023, USD Million
TABLE 68 Rest of North America Laboratory Developed Tests Market by Application, 2024 - 2031, USD Million
TABLE 69 Rest of North America Laboratory Developed Tests Market by Technology, 2020 - 2023, USD Million
TABLE 70 Rest of North America Laboratory Developed Tests Market by Technology, 2024 - 2031, USD Million
TABLE 71 Key Information – neogenomics, inc.
TABLE 72 Key Information – GUARDANT HEALTH, INC.
TABLE 73 Key Information – Qiagen N.V.
TABLE 74 Key information – Quest Diagnostics Incorporated
TABLE 75 Key Information – Abbott Laboratories
TABLE 76 Key Information – Siemens Healthineers AG
TABLE 77 key information – Illumina, Inc.
TABLE 78 Key Information – Bio-Rad Laboratories, Inc.
TABLE 79 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 80 Key Information – Eurofins Scientific SE
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Laboratory Developed Tests Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Laboratory Developed Tests Market
FIG 4 Porter’s Five Forces Analysis – Laboratory Developed Tests Market
FIG 5 North America Laboratory Developed Tests Market share by Application, 2023
FIG 6 North America Laboratory Developed Tests Market share by Application, 2031
FIG 7 North America Laboratory Developed Tests Market by Application, 2020 - 2031, USD Million
FIG 8 North America Laboratory Developed Tests Market share by Technology, 2023
FIG 9 North America Laboratory Developed Tests Market share by Technology, 2031
FIG 10 North America Laboratory Developed Tests Market by Technology, 2020 - 2031, USD Million
FIG 11 North America Laboratory Developed Tests Market share by Country, 2023
FIG 12 North America Laboratory Developed Tests Market share by Country, 2031
FIG 13 North America Laboratory Developed Tests Market by Country, 2020 - 2031, USD Million
FIG 14 Swot Analysis: Neogenomics, Inc.
FIG 15 Swot Analysis: Guardant Health, Inc.
FIG 16 Recent strategies and developments: Qiagen N.V.
FIG 17 Swot Analysis: Qiagen N.V.
FIG 18 SWOT Analysis: Quest Diagnostics Incorporated
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 SWOT Analysis: Siemens Healthineers AG
FIG 21 Swot Analysis: Illumina, Inc.
FIG 22 SWOT Analysis: Bio-Rad Laboratories, Inc.
FIG 23 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 24 SWOT Analysis: Eurofins Scientific SEs